American researchers suggest that vasculopathic patients who undergo transapical transcatheter aortic valve replacement (TAVR) appear to be more likely to experience adverse events and longer recovery times when compared with those who undergo transfemoral TAVR. However, no differences were observed in stroke risk, and aortic regurgitation was less likely with the transapical approach.
Source: Circulation, June 2, 2015.
